Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of Tangning Tongluo Tablets in non-proliferative diabetic retinopathy (yin deficiency internal heat, ocular collateral blood stasis pattern)
CTR20250473Phase 3Active
- Sponsor
- Bailing Yuxiu
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tangningtongluo in diabetic retinopathy (NPDR), sponsored by Bailing Yuxiu. Started Apr 2025; status: active.
02
Drugs
tangningtongluo
03
Conditions
diabetic retinopathy (NPDR)
Beyond the preview
Go deeper on CTR20250473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250473.